DNA Damage and Repair Mechanisms

Fanconi anemia is a genetic disorder characterized by a defect in the DNA repair mechanism, particularly in the repair of interstrand cross-links. This condition arises from mutations in genes responsible for the Fanconi anemia pathway, which is crucial for repairing damaged DNA. As a result, individuals with Fanconi anemia exhibit increased sensitivity to agents that cause DNA cross-linking, leading to a higher risk of cancer and other serious health issues due to their compromised ability to maintain genomic stability.

Nucleotide excision repair (NER) is designed to address bulky DNA lesions, such as those caused by UV radiation, by excising a short segment of the DNA strand that includes the damage. In contrast, base excision repair (BER) specifically targets minor, non-helix-distorting base lesions and employs DNA glycosylases to remove only the damaged base, followed by further processing to restore the DNA strand. This distinction highlights the different types of damage each repair mechanism is equipped to handle, with NER being more comprehensive in its approach to larger, more complex lesions.

NHEJ, or Non-Homologous End Joining, is crucial for V(D)J recombination, a process that generates diverse antibodies and T-cell receptors in lymphocytes, essential for a functional immune response. Additionally, NHEJ repairs double-strand breaks in oncogenes, preventing genomic instability that can lead to cancer. Defects in NHEJ thus compromise both immune system development and the integrity of the genome, resulting in increased susceptibility to cancers and immunodeficiency syndromes. This dual role highlights the importance of NHEJ in maintaining both immune function and genomic stability.

In nucleotide excision repair, after the damaged section of DNA is removed, a gap remains in the DNA strand. DNA Polymerase I (DNA Pol I) is responsible for filling this gap by synthesizing new DNA nucleotides complementary to the template strand. Following this synthesis, DNA ligase then seals the newly synthesized DNA to the existing strand, ensuring the integrity and continuity of the DNA molecule. This coordinated action of DNA Pol I and DNA ligase is crucial for effective DNA repair and maintaining genomic stability.

Exogenous mutagenic agents are external factors that induce mutations in DNA. UV radiation leads to pyrimidine dimerization, disrupting normal base pairing. Nitrous acid causes deamination of bases, converting cytosine to uracil, which can lead to mispairing during DNA replication. Ionizing radiation generates free radicals that can cause double-strand breaks in the DNA helix, posing a significant threat to genomic integrity. In contrast, spontaneous deamination and loss of purine bases are intrinsic processes and not considered exogenous mutagens.

In mismatch repair, the process begins with the identification of the mismatched base pair in the newly synthesized DNA strand. The repair mechanism relies on the fact that the parental strand is methylated, which helps distinguish it from the newly synthesized strand. Once the mismatch is recognized, enzymes remove the section of the new strand containing the error. DNA polymerase III then synthesizes new DNA to fill the gap, using the methylated parental strand as a template to ensure accurate base pairing. This ensures the integrity of the genetic information is maintained.

Human cells experience a significant amount of spontaneous damage daily, particularly to purine bases, which are essential components of DNA and RNA. On average, about 10,000 purine bases are lost per cell each day due to various factors, including hydrolysis and oxidative stress. This high turnover necessitates efficient DNA repair mechanisms to maintain genomic integrity and prevent mutations, highlighting the dynamic nature of cellular processes and the importance of maintaining cellular health.

Base excision repair (BER) is a cellular process that corrects DNA damage, particularly from non-bulky lesions. It begins with DNA glycosylases, which specifically recognize and remove damaged bases by cleaving the N-glycosidic bond. This action releases the abnormal base and generates an apurinic/apyrimidinic (AP) site. Following this, additional enzymes facilitate the removal of the sugar-phosphate backbone and fill in the correct nucleotide, completing the repair. This mechanism is crucial for maintaining genomic stability by addressing small-scale DNA damage effectively.

Mismatch repair (MMR) proteins identify the parental strand by recognizing its methylation status. In many organisms, the parental DNA strand is methylated at specific sequences, while the newly synthesized daughter strand remains unmethylated immediately after replication. This difference allows MMR proteins to distinguish between the two strands, enabling them to correct errors that occur during DNA replication by targeting the mismatched bases on the unmethylated daughter strand. This mechanism ensures genomic stability by maintaining the integrity of the DNA sequence.

Homologous recombination (HR) primarily occurs during the S and G2 phases of the cell cycle when sister chromatids are available for accurate repair. In contrast, nonhomologous end joining (NHEJ) can function throughout the cell cycle, including the G1 phase, making it a more versatile repair mechanism for double-strand breaks. Therefore, the statement that HR can occur at any phase while NHEJ is restricted to late S and G2 phases is incorrect.

PARP inhibitors target the repair mechanism of single-strand breaks in DNA. In BRCA-deficient tumors, the cells lack the ability to repair double-strand breaks effectively due to the absence of functional BRCA1/2 proteins. When PARP is inhibited, single-strand breaks accumulate and eventually lead to double-strand breaks. Since BRCA-deficient cells cannot repair these breaks, they undergo synthetic lethality, resulting in cell death. This mechanism exploits the vulnerability of cancer cells with BRCA mutations, making PARP inhibitors an effective therapeutic strategy for these tumors.

Homologous recombination (HR) is termed 'error-free' because it utilizes a homologous DNA sequence as a template for repair, ensuring that the genetic information is accurately restored. This mechanism allows for precise replacement of lost or damaged DNA, minimizing the risk of mutations that can occur during repair processes like non-homologous end joining (NHEJ), which can join broken ends incorrectly. By relying on a template, HR maintains genetic fidelity, making it a more reliable method for repairing double-strand breaks in DNA.

Nonhomologous end joining (NHEJ) is a repair mechanism that directly joins broken DNA ends without the need for a homologous template. This process can result in the loss of nucleotides at the site of the break, as the ends are often processed to make them compatible for ligation. Consequently, the absence of a template means that any missing DNA cannot be accurately restored, leading to potential mutations or genomic instability, which characterizes NHEJ as error-prone.

Hereditary nonpolyposis colorectal cancer (HNPCC), also known as Lynch syndrome, is linked to genetic mutations that impair the body's ability to correct DNA replication errors. These errors typically occur during cell division and can lead to cancer if not repaired. The proteins involved in mismatch repair play a crucial role in identifying and fixing these errors. When mutations occur in the genes encoding these proteins, the repair process is compromised, increasing the risk of colorectal and other types of cancer. Thus, the association between HNPCC and mismatch repair mutations is fundamental to understanding the disease's genetic basis.

Xeroderma pigmentosum (XP) is a genetic disorder characterized by extreme sensitivity to ultraviolet (UV) light, leading to a high risk of skin cancer. This condition arises from mutations in genes responsible for nucleotide excision repair (NER), a critical DNA repair pathway that removes bulky DNA lesions caused by UV radiation. In individuals with XP, the inability to effectively repair these lesions results in the accumulation of DNA damage, which manifests as skin abnormalities and an increased susceptibility to malignancies. Thus, the defect in nucleotide excision repair is central to the pathology of XP.

Base excision repair (BER) initiates with DNA glycosylase, which recognizes and removes damaged bases, creating an abasic site. Following this, AP endonuclease cleaves the DNA backbone at the abasic site, allowing for the removal of the sugar phosphate residue by deoxyribose phosphate lyase. This prepares the site for DNA synthesis, where DNA Pol I fills in the gap with the correct nucleotide. Finally, DNA ligase seals the nicks in the sugar-phosphate backbone, completing the repair process. This sequence ensures effective restoration of DNA integrity after damage.

UvrABC excinuclease is a key enzyme in nucleotide excision repair (NER) that specifically recognizes bulky DNA lesions, such as UV-induced thymine dimers. It operates by binding to the damaged site and making incisions on both sides of the lesion, which allows for the removal of the damaged DNA segment. This excision creates a gap that can then be filled in by DNA polymerases, ensuring the integrity of the DNA is restored. Thus, UvrABC excinuclease plays a crucial role in maintaining genomic stability by repairing UV-induced damage.

Mismatch repair (MMR) is a crucial DNA repair mechanism that corrects errors that occur during DNA replication, such as mispaired bases. By efficiently identifying and repairing these mismatches, MMR significantly enhances the fidelity of DNA replication. This process reduces the error rate from 1 in 10 million nucleotides (10⁷) to 1 in 1 billion nucleotides (10⁹), demonstrating the effectiveness of MMR in maintaining genetic stability and preventing mutations that could lead to diseases, including cancer.